FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely

Lignende værker

• FDA Considers a New Paradigm For Over-the-Counter Medications: More Power—but More Burdens—for Pharmacists and Pharmacies
  af: Barlas, Stephen
  Udgivet: (2012)
• FDA Pushes Plans for Drug Compounding: More Scrutiny for Hospital Pharmacies
  af: Barlas, Stephen
  Udgivet: (2013)
• The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?
  af: Barlas, Stephen
  Udgivet: (2016)
• FDA Wants Companies to Simplify Drug Packaging, Naming, and Labeling To Reduce Medication Errors
  af: Barlas, Stephen
  Udgivet: (2010)
• FDA Requires New Labeling for Some Opioids: Modest Changes Walk Narrow Political Line
  af: Barlas, Stephen
  Udgivet: (2013)